Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis

Clinical Immunology

Volumn 122, Issue 2, 2007, Pages 187-193

  Zhang, Ai Hua ^a   Chen, Min ^a   Gao, Ying ^a   Zhao, Ming Hui ^a   Wang, Hai Yan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

ANCA; Microscopic polyangiitis; Myeloperoxidase; Oxidation activity; Prophylthiouracil

Indexed keywords

IMMUNOGLOBULIN G; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME METABOLISM; FEMALE; HUMAN; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIMETABOLITES; FEMALE; HAPLORHINI; HUMANS; MALE; MIDDLE AGED; MYELOBLASTIN; OXIDATION-REDUCTION; PEROXIDASE; PROPYLTHIOURACIL; VASCULITIS, HYPERSENSITIVITY; WEGENER GRANULOMATOSIS;

EID: 33846063344     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.09.011     Document Type: Article

References (25)

1. Dolman K.M., Gans R.O., Vervaat T.J., Zevenbergen G., Maingay D., Nikkels R.E., Donker A.J., Borne A.E., and Goldschmeding R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342 (1993) 651-652
2. Harper L., Cockwell P., and Savage C.O. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol. Dial. Transplant. 13 (1998) 455-458
3. Yu F., Zhao M.H., Zhang Y.K., Zhang Y., and Wang H.Y. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin. Exp. Immunol. 139 (2005) 569-574
4. Gao Y., Ye H., Yu F., Guo X.H., and Zhao M.H. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin. Immunol. 117 (2005) 87-93
5. Gao Y., Zhao M.H., Guo X.H., Xin G., Gao Y., and Wang H.Y. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr. Res. 30 (2004) 205-213
6. Ye H., Zhao M.H., Gao Y., Guo X.H., and Wang H.Y. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Clin. Exp. Immunol. 138 (2004) 179-182
7. Ye H., Gao Y., Guo X.H., and Zhao M.H. Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis. Clin. Exp. Immunol. 142 (2005) 116-119
8. Falk R.J., Becker M., Terrell R., and Jennette J.C. Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin. Exp. Immunol. 89 (1992) 274-278
9. Chang L., and Savige J. Studies to demonstrate inhibition of functional activity of neutrophil lysosomal enzymes with ANCA. Adv. Exp. Med. Biol. 336 (1993) 97-100
10. Griffin S.V., Chapman P.T., Lianos E.A., and Lockwood C.M. The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int. 55 (1999) 917-925
11. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 37 (1994) 187-192
12. Merkel P.A. Drug-induced vasculitis. Rheum. Dis. Clin. North Am. 27 (2001) 849-862
13. Zhao M.H., and Lockwood C.M. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J. Immunol. Methods 197 (1996) 121-130
14. 2. Enzymes 3 (1979) 345-353
15. Okamura Y., Shigemasa C., and Tatsuhara T. Pharmacokinetics of methimazole in normal subjects and hyperthyroid patients. Endocrinol. Jpn. 33 (1986) 605-615
16. Rosseel M.T., and Lefebvre R.A. High-performance liquid chromatographic determination of propylthiouracil in plasma. J. Chromatogr. 507 (1990) 247-251
17. Jiang X., Khursigara G., and Rubin R.L. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 266 (1994) 810-813
18. Lee E., Hirouchi M., Hosokawa M., Sayo H., Kohno M., and Kariya K. Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem. Pharmacol. 37 (1988) 2151-2153
19. Lee E., Miki Y., Hosokawa M., Sayo H., and Kariya K. Oxidative metabolism of prophylthiouracil by peroxidase from rat bone marrow. Xenobiotica 18 (1988) 1135-1142
20. Zhao M.H., Chen M., Gao Y., and Wang H.Y. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 69 (2006) 1477-1481
21. van de Water J., Fregeau D., Davis P., Ansari A., Danner D., Leung P., Coppel R., and Gershwin M.E. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J. Immunol. 141 (1988) 2321-2324
22. Rowley M.J., Mcneilage L.J., Armstrong J.M., and Mackay I.R. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis. Clin. Immunol. Immunopathol. 60 (1991) 356-370
23. Falk R.J., Terrell R.S., Charles L.A., and Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4115-4119
24. Charles L.A., Caldas M.L.R., Falk R.J., Terrell R.S., and Jennette J.C. Antibodies against granule proteins activate neutrophil in vitro. J. Leukocyte Biol. 50 (1991) 539-546
25. Rao N.V., Wehner N.G., Marshall B.C., Gray W.R., Gray B.H., and Hoidal J.R. Characterization of proteinase-3 (PR3), a neutrophil serine proteinase. J. Biol. Chem. 266 (1991) 9540-9548